Professor Andrew Tutt
Professor Tutt is a Consultant Oncologist in the multidisciplinary Breast Unit at Guy’s and St Thomas’ NHS Foundation Trust. He is also Professor of Breast Oncology and Director of the Breast Cancer Now Research Unit at King’s College London and has recently been appointed Director of the Breast Cancer Now Toby Robins Research Centre and Head of the Division of Breast Cancer Research at the Institute of Cancer Research. Prior to this, he gained a Research Training Fellowship from the Medical Research Council to work in Professor Alan Ashworth’s laboratory at the Institute of Cancer Research. Here he worked on functions of the BRCA2 breast cancer predisposition gene.
He has since developed a translational laboratory for Triple Negative Breast Cancer. He leads a clinical trial programme focusing on Triple Negative forms of breast cancer and cancers associated with functional deficiencies in BRCA1/2, leading to the clinical development of PARP inhibitors. He is Chief Investigator for the recently reported multicentre UKCRN Triple Negative Trial and is Global Study Chair of the ‘OlympiA’ study – an adjuvant PARP inhibitor trial in patients with germline BRCA1/2 mutations and breast cancer.